Court urges gov't to settle suits with hepatitis C patients

Court urges gov't to settle suits with hepatitis C patients

OSAKA, Japan - Plaintiffs seeking damages over hepatitis-C diseases enter the Osaka High Court to attend a court session on Nov. 7. The court called on the government and drug makers for a negotiated settlement of damages lawsuits filed by people who were infected with hepatitis-C through tainted blood products.

  • Product Code
  • ILEA001124834
  • Registered date
  • 2007/11/07 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2007 Kyodo News
  • Media size
  • 1864 × 1197 pixel
  • Resolution
  • dpi
  • Deployment size
  • 629.68(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    High court denies Japanese gov't funds for Korean schools

    High court denies Japanese gov't funds for Korean schools

    Officials hold a banner that reads "unjust ruling" in front of the Tokyo High Court on Oct. 30, 2018, after the court upheld a lower court ruling that rejected a damages suit filed by graduates of the Tokyo Korean Junior and Senior High School over the government's exclusion of Korean schools from a tuition waiver program that covers most high schools in Japan. (Kyodo) ==Kyodo
      High court denies Japanese gov't funds for Korean schools

      High court denies Japanese gov't funds for Korean schools

      Officials hold a banner that reads "unjust ruling" in front of the Tokyo High Court on Oct. 30, 2018, after the court upheld a lower court ruling that rejected a damages suit filed by graduates of the Tokyo Korean Junior and Senior High School over the government's exclusion of Korean schools from a tuition waiver program that covers most high schools in Japan. (Kyodo) ==Kyodo
        'Green owner' program plaintiffs meet press

        'Green owner' program plaintiffs meet press

        OSAKA, Japan - Plaintiffs meet the press in Osaka on Oct. 9, 2014, after the Osaka District Court ordered the government to pay 85 people a combined 91 million yen in damages for failing to sufficiently warn them of the risks of investment in state-owned forests. The plaintiffs in the lawsuit over the "green owner" program had sought about 500 million yen in compensation.
          Nepalese acquitted over 1997 murder

          Nepalese acquitted over 1997 murder

          TOKYO, Japan - Hiroshi Kamiyama (C), who heads the defense counsel for Govinda Prasad Mainali, and other members of the counsel smile during a press conference in Tokyo on Nov. 7, 2012, after the Tokyo High Court exonerated the Nepalese man of a 1997 murder. The court acquitted Mainali, who had been sentenced to life in prison for the killing of a Japanese woman.
            Nepalese acquitted over 1997 murder

            Nepalese acquitted over 1997 murder

            TOKYO, Japan - A supporter (C front) for Govinda Prasad Mainali holds a sheet of paper bearing the message "Acquitted in retrial," in front of the Tokyo High Court on Nov. 7, 2012, shortly after the Nepalese man was exonerated of the 1997 murder of a Japanese woman. The court acquitted Mainali, who had been sentenced to life in prison for the killing.
              Plaintiffs of Iressa cancer drug case

              Plaintiffs of Iressa cancer drug case

              TOKYO, Japan - Three deceased patients' relatives who sued the Japanese government and the Japanese unit of British pharmaceutical company AstraZeneca PLC, demanding compensation for the side effects caused by the lung cancer drug Iressa, walk to the Tokyo High Court on Nov. 15, 2011. The high court on the same day ruled the government and AstraZeneca K.K. are not responsible for damages, overturning a lower court ruling. The plaintiffs sought a combined 77 million yen in compensation. (Kyodo)
                Basic agreement on hepatitis B infections

                Basic agreement on hepatitis B infections

                TOKYO, Japan - Japanese health minister Ritsuo Hosokawa (R) and Mieko Taniguchi, the leader of plaintiffs in damages suits brought against the state over contractions of hepatitis B, shake hands at the health ministry in Tokyo on June 28, 2011, after the Japanese government and the plaintiffs signed a basic agreement. The government will pay damages to people infected with the hepatitis B virus through reused needles in group vaccinations between 1948 and 1988. (Kyodo)
                  AstraZeneca ordered to pay damages over side-effects of Iressa

                  AstraZeneca ordered to pay damages over side-effects of Iressa

                  OSAKA, Japan - Supporters of plaintiffs hold up banners in front of the Osaka District Court on Feb. 25, 2011, declaring victory in their case after the court ordered the Japan unit of British drugmaker AstraZeneca PLC to pay a total of 60.5 million yen to nine of 11 plaintiffs who sought compensation over side-effects caused by the lung cancer drug Iressa. (Kyodo)
                    AstraZeneca ordered to pay damages over side-effects of Iressa

                    AstraZeneca ordered to pay damages over side-effects of Iressa

                    OSAKA, Japan - Hideki Shimizu (R), a plaintiff who demanded compensation over side effects caused by the lung cancer drug Iressa, speaks at a press conference in Osaka on Feb. 25, 2011, together with Akio Chikazawa, a plaintiff in a similar suit filed in Tokyo. The Osaka District Court the same day ordered the Japan unit of British drugmaker AstraZeneca PLC to pay a total of 60.5 million yen to nine out of 11 plaintiffs, including Shimizu. (Kyodo)
                      Hepatitis B sufferers to accept court proposal

                      Hepatitis B sufferers to accept court proposal

                      TOKYO, Japan - Mieko Taniguchi, the leader of plaintiffs suffering from hepatitis B, speaks at a meeting in Tokyo on Jan. 22, 2011. The plaintiffs decided the same day to accept a court-proposed settlement plan for lawsuits against the government on condition that the state offers an apology and blanket compensation. (Kyodo)